Use of a national registry to assess palivizumab use

I. Mitchell, B. Paes, K. Lanctot (Calgary, AB, Hamilton, ON, Toronto, ON, Canada)

Source: Annual Congress 2008 - Paediatric respiratory epidemiology II: air pollution studies and infectious disease epidemiology
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Mitchell, B. Paes, K. Lanctot (Calgary, AB, Hamilton, ON, Toronto, ON, Canada). Use of a national registry to assess palivizumab use. Eur Respir J 2008; 32: Suppl. 52, 4056

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical effectiveness of recommended antibiotics in COVID19 pneumonias; assessing national referral centre guidance
Source: Virtual Congress 2021 – COVID - 19 treatments
Year: 2021


COPD admissions and inhaled medications: Escalating prescription costs but no evidence of effect. A national primary care study
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013

Outcomes of two population-based approaches to prophylaxis with palivizumab
Source: Eur Respir J 2004; 24: Suppl. 48, 23s
Year: 2004

The audit of standard of assessment for the long-term oxygen and justification of its prescription as per the national guidelines
Source: Annual Congress 2007 - Pulmonary rehabilitation beyond training
Year: 2007


Implementation of the new regulations of SEPAR on the treatment of smoking in hospitalized patients
Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations
Year: 2019

From guidelines to real life- data from the EMBARC registry and national audits 
Source: International Congress 2017 – Bronchiectasis: from guidelines to real life
Year: 2017


Management of community acquired pneumonia in UK hospitals: a survey of the availability of local guidelines and severity assessment tools
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


Is documentation of admissions for asthma adequate to assess adherence to BTS/SIGN guidelines?
Source: Eur Respir J 2005; 26: Suppl. 49, 46s
Year: 2005

Factors associated with compliance with palivizumab treatment in the Canadian rSV evaluation study for synagis (CARESS) registry (32005-2011)
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012

Oxygen prescription and administration audit at a UK teaching hospital: compliance with British thoracic society (BTS) guidelines and the impact of electronic prescribing
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009

Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015


The impact of national recommendations on antibiotic treatment of community acquired pneumonia. Do pediatricians follow the national guidelines?
Source: International Congress 2017 – Pulmonary infection and inflammation
Year: 2017


An assessment of the use of palivizumab over 12 years from a Canadian Registry (CARESS).
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019


FAdoi Study on CAP (FASTCAP): retrospective study prior to implementation of Italian internal medicine guidelines
Source: Eur Respir J 2005; 26: Suppl. 49, 257s
Year: 2005

Management of COPD in primary care: an audit of NICE guidance and cost effectiveness
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017


The use of prescribing surveillance systems to monitor prescribing behaviour in primary care: a two-year study of respiratory prescribing patterns in Hampshire, England
Source: Eur Respir J 2004; 24: Suppl. 48, 602s
Year: 2004

The primary care routine data registry BeoNet: First pilot phase results for COPD research
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015

Use of inhaled corticosteroids and the risk of osteoporosis: an international cohort study
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Year: 2018

Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement
Source: Eur Respir J 2016; 47: 429-460
Year: 2016



Prescription patterns and treatment adherence of asthma controller therapy in children in a Dutch primary care database
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013